New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta once daily experienced significant pain reduction.
Ads by Google
Arthritis Pain Treatment
Patients receiving every four-week subcutaneous injections of golimumab 50 mg and 100 mg and weekly methotrexate experienced significant improvements in the signs and symptoms of rheumatoid arthritis.
Patients with moderately-to-severely active rheumatoid arthritis who were previously treated with anti-tumor necrosis factor-alpha agents, experienced significant improvements in signs and symptoms and physical function after receiving every four-week subcutaneous injections of golimumab.
We have too few pediatric rheumatologists in the United States, but this is not the only problem in the delay or inacurrate diagnosis of juvenile rheumatoild arthritis (JRA).
Arthritis affects one in every four adults in Wisconsin, and nationally it is the most common cause of disability. Yet state health officials report that if arthritis sufferers exercise for short periods of time, despite their discomfort, they can come one step closer to relieving some of their aches and pains.
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity-an important health strategy for managing diabetes.
Wyeth Pharmaceuticals has commenced patient dosing in the next Phase 2b clinical trial of TRU-015 in patients with rheumatoid arthritis (RA). In collaboration with Trubion, Wyeth Pharmaceuticals is developing TRU-015, SBI-087 and other CD20-directed products.
Physical Activity is Vital for Successful Management of Both Arthritis and Diabetes.
Wyeth Pharmaceuticals has initiated a Phase 1 clinical trial of SBI-087, a next-generation drug candidate for the treatment of rheumatoid arthritis (RA). In collaboration with Trubion, Wyeth Pharmaceuticals is developing SBI-087 and other CD20-directed products. SBI-087 for RA builds on Trubion and Wyeth's clinical experience with Trubion's lead compound, TRU-015, and is based on Trubion's Small Modular ImmunoPharmaceutical (SMIP) technology.
Study assessed the association between decline-to-fill rates as they relate to out-of-pocket expense for members initiating TNF-blocker therapy for the treatment of inflammatory conditions such as rheumatoid arthritis.
More than 20 million Americans suffer from osteoarthritis, with half a million Americans having a total joint replacement each year. A new study to be published in the April 2008 edition (Volume 22, issue No 4) of the journal of Phytotherapy Research shows Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, was shown to reduce all osteoarthritis symptoms by 56 percent. The study revealed a particularly high efficacy of Pycnogenol for lowering joint pain by 55 percent.
Abbott has received approval from the Japanese Ministry of Health, Labour and Welfare for HUMIRA for the treatment of rheumatoid arthritis in patients with inadequate response to conventional therapy.
FDA has approved Bristol-Myers Squibb's ORENCIA for reducing signs and symptoms in pediatric patients six years and older with moderately to severely active polyarticular juvenile idiopathic arthritis.
Common genetic variants linked to arthritis may also play a role in human height.
About 294,000 U.S. children and teenagers under age 18 (or one in 250 children) have been diagnosed with arthritis or another rheumatologic condition.
For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness
Researchers carried out a genome-wide association study of nearly 400 individuals with rheumatoid arthritis and identified a novel variant on chromosome 6 that increases the risk for developing the disease.
A team of researchers has discovered two genes linked to a disabling form of arthritis called ankylosing spondylitis.
Life expectancy for rheumatoid arthritis patients has not improved over the past 4 decades.
Work limitation due to arthritis in all working-age adults ranges from a low of 3.4 percent in Hawaii to a high of 15 percent in Kentucky.
Researchers have identified a genetic region associated with increased risk of rheumatoid arthritis (RA).
Health Canada advised the public not to use the health product Asam Urat Flu Tulang, PJ Dewandaru promoted to treat joint pain, rheumatism and arthritis.
Health Canada advised consumers not to use Khun-Phra promoted to treat arthritis and joint pain.
For patients with rheumatoid arthritis under routine medical supervision, an 8-week meditation class plus a 4-month maintenance program had beneficial effects.
Small Bone Innovations's Artelon STT Spacer for early to mid-stage osteo-arthritis has been cleared by the FDA for marketing in the US.